Performance and Impact of the Sepsis ImmunoScore
ConditionSepsis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPrenosis, Inc.
About this trial
The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Eligibility criteria
Qualifiers
Adult (age 18 years or older) patients presenting to hospitals and emergency departments of medical institutions across the United States.
Adult (age 18 years or older) patients suspected of sepsis.
Disqualifiers
none
Trial design
Treatments tested in this trial
- Sepsis ImmunoScore
Treatment groups
5,000 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov